Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species
Open Access
- 7 April 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Plant Science
- Vol. 12, 650820
- https://doi.org/10.3389/fpls.2021.650820
Abstract
The increase in the world population, the advent of new infections and health issues, and the scarcity of natural biological products have spotlighted the importance of recombinant protein technology and its large-scale production in a cost-effective manner. Microalgae have become a significant promising platform with the potential to meet the increasing demand for recombinant proteins and other biologicals. Microalgae are safe organisms that can grow rapidly and are easily cultivated with basic nutrient requirements. Although continuous efforts have led to considerable progress in the algae genetic engineering field, there are still many hurdles to overcome before these microorganisms emerge as a mature expression system. Hence, there is a need to develop efficient expression approaches to exploit microalgae for the production of recombinant proteins at convenient yields. This study aimed to test the ability of the DNA geminiviral vector with Rep-mediated replication to transiently express recombinant proteins in the freshwater microalgal species Chlamydomonas reinhardtii and Chlorella vulgaris using Agrobacterium-mediated transformation. The SARS-CoV-2 receptor binding domain (RBD) and basic fibroblast growth factor (bFGF) are representative antigen proteins and growth factor proteins, respectively, that were subcloned in a geminiviral vector and were used for nuclear transformation to transiently express these proteins in C. reinhardtii and C. vulgaris. The results showed that the geminiviral vector allowed the expression of both recombinant proteins in both algal species, with yields at 48 h posttransformation of up to 1.14 μg/g RBD and 1.61 ng/g FGF in C. vulgaris and 1.61 μg/g RBD and 1.025 ng/g FGF in C. reinhardtii. Thus, this study provides a proof of concept for the use of DNA viral vectors for the simple, rapid, and efficient production of recombinant proteins that repress the difficulties faced in the genetic transformation of these unicellular green microalgae. This concept opens an avenue to explore and optimize green microalgae as an ideal economically valuable platform for the production of therapeutic and industrially relevant recombinant proteins in shorter time periods with significant yields.Keywords
Funding Information
- Chulalongkorn University (CU_GI_62_08_33_01)
This publication has 78 references indexed in Scilit:
- In Plant Activation: An Inducible, Hyperexpression Platform for Recombinant Protein Production in PlantsTHE PLANT CELL ONLINE, 2013
- Vaccination against Influenza with Recombinant Hemagglutinin Expressed by Schizochytrium sp. Confers Protective ImmunityPLOS ONE, 2013
- Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria TransmissionPLOS ONE, 2012
- Algae as Protein Factories: Expression of a Human Antibody and the Respective Antigen in the Diatom Phaeodactylum tricornutumPLOS ONE, 2011
- Strategies for high-level recombinant protein expression in transgenic microalgae: A reviewBiotechnology Advances, 2010
- Micro-algae come of age as a platform for recombinant protein productionBiotechnology Letters, 2010
- Foreign protein production using plant cell and organ cultures: Advantages and limitationsBiotechnology Advances, 2009
- Production of recombinant proteins by microbes and higher organismsBiotechnology Advances, 2009
- Factors effecting expression of vaccines in microalgaeBiologicals, 2009
- Microbial factories for recombinant pharmaceuticalsMicrobial Cell Factories, 2009